Current Value
$19.051 Year Return
Current Value
$19.051 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -21.39% | $164.54M | 0.85% |
TAIL | -16.93% | $99.63M | 0.59% |
BTAL | -11.02% | $296.22M | 1.43% |
USDU | -10.94% | $162.43M | 0.5% |
IVOL | -10.64% | $347.03M | 1.02% |
BILS | -9.66% | $3.81B | 0.1356% |
SPTS | -8.92% | $5.80B | 0.03% |
XHLF | -8.87% | $1.73B | 0.03% |
CARY | -8.85% | $347.36M | 0.8% |
XONE | -8.28% | $625.28M | 0.03% |
KMLM | -8.23% | $188.90M | 0.9% |
FTSM | -7.98% | $6.37B | 0.45% |
IBTG | -7.87% | $1.92B | 0.07% |
UUP | -7.80% | $201.63M | 0.77% |
VGSH | -7.68% | $22.80B | 0.03% |
SCHO | -7.43% | $11.03B | 0.03% |
FMF | -7.37% | $158.70M | 0.95% |
LDUR | -7.27% | $929.65M | 0.5% |
UTWO | -7.12% | $379.52M | 0.15% |
PSQA | -7.07% | $35.44M | 0.2% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
XGN | 33.95% | $152.37M | +285.08% | 0.00% |
TBRG | 32.34% | $340.43M | +102.50% | 0.00% |
PLTR | 30.63% | $311.79B | +411.10% | 0.00% |
CARG | 30.56% | $3.33B | +38.31% | 0.00% |
MKL | 28.66% | $24.88B | +26.79% | 0.00% |
APPS | 28.57% | $625.84M | +250.30% | 0.00% |
ADMA | 28.22% | $4.33B | +61.82% | 0.00% |
HONE | 26.05% | $523.36M | +12.08% | 2.69% |
IOVA | 25.90% | $584.38M | -76.32% | 0.00% |
RNA | 25.80% | $3.54B | -21.10% | 0.00% |
FLXS | 25.68% | $203.13M | +23.94% | 1.82% |
AKAM | 25.29% | $11.62B | -12.03% | 0.00% |
G | 25.12% | $7.87B | +41.34% | 1.41% |
AUDC | 25.03% | $289.67M | -7.58% | 3.70% |
TBCH | 24.97% | $292.02M | +2.29% | 0.00% |
DOCS | 24.55% | $11.14B | +124.91% | 0.00% |
DOCN | 24.52% | $2.59B | -18.46% | 0.00% |
VNET | 24.42% | $1.87B | +211.89% | 0.00% |
IAG | 24.32% | $4.27B | +95.01% | 0.00% |
SPOT | 24.21% | $142.55B | +125.38% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
LMBS | 0.01% | $5.11B | 0.64% |
SHM | 0.07% | $3.41B | 0.2% |
SUSB | 0.11% | $988.77M | 0.12% |
OWNS | -0.16% | $129.31M | 0.3% |
UNG | -0.18% | $360.54M | 1.06% |
IBTP | -0.23% | $143.92M | 0.07% |
NUBD | 0.24% | $397.77M | 0.16% |
FLGV | -0.24% | $1.03B | 0.09% |
TOTL | -0.27% | $3.84B | 0.55% |
BOND | 0.28% | $5.67B | 0.7% |
IBMS | 0.29% | $89.64M | 0.18% |
DFIP | -0.30% | $925.62M | 0.11% |
JPST | -0.31% | $31.90B | 0.18% |
GSY | -0.37% | $2.74B | 0.22% |
IBTO | -0.39% | $352.69M | 0.07% |
TESL | 0.39% | $32.49M | 1.2% |
FIXD | 0.45% | $3.42B | 0.65% |
VNLA | -0.45% | $2.62B | 0.23% |
VMBS | 0.47% | $14.48B | 0.03% |
MMIN | 0.47% | $336.10M | 0.3% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FRDM | 22.55% | $1.19B | 0.49% |
EMXC | 22.12% | $13.60B | 0.25% |
GWX | 21.99% | $707.37M | 0.4% |
CGBL | 21.95% | $2.57B | 0.33% |
IZRL | 21.81% | $116.38M | 0.49% |
EWD | 21.69% | $377.82M | 0.54% |
XCEM | 21.56% | $1.16B | 0.16% |
PXF | 21.56% | $2.03B | 0.43% |
PRNT | 21.54% | $76.77M | 0.66% |
ESGE | 21.47% | $5.01B | 0.26% |
CWI | 21.44% | $1.88B | 0.3% |
AVEM | 21.44% | $10.77B | 0.33% |
SPEU | 21.41% | $690.06M | 0.07% |
FXC | 21.37% | $93.16M | 0.4% |
ILF | 21.37% | $1.65B | 0.48% |
FYLD | 21.32% | $397.39M | 0.59% |
EEM | 21.27% | $18.30B | 0.72% |
IEMG | 21.26% | $95.71B | 0.09% |
ACWX | 21.22% | $6.44B | 0.32% |
BBCA | 21.20% | $8.38B | 0.19% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PCRX | -34.64% | $1.07B | +7.16% | 0.00% |
AVD | -27.34% | $140.05M | -52.08% | 0.00% |
MITK | -21.05% | $466.12M | -9.95% | 0.00% |
CLX | -18.54% | $15.36B | -5.89% | 3.90% |
PINC | -17.82% | $1.79B | +18.29% | 3.85% |
EL | -14.97% | $31.87B | -16.78% | 1.91% |
SPTN | -12.47% | $898.36M | +47.04% | 3.30% |
MRK | -12.13% | $206.88B | -34.53% | 3.89% |
FIVN | -11.75% | $2.04B | -37.58% | 0.00% |
WBTN | -11.72% | $1.22B | -53.77% | 0.00% |
PUBM | -11.70% | $614.92M | -38.70% | 0.00% |
SAVA | -11.17% | $97.10M | -81.34% | 0.00% |
PYPL | -11.10% | $74.21B | +27.95% | 0.00% |
NFE | -10.66% | $1.06B | -80.94% | 0.00% |
MOH | -10.56% | $12.95B | -19.36% | 0.00% |
ATKR | -10.37% | $2.53B | -43.11% | 1.69% |
KVUE | -9.44% | $40.13B | +14.15% | 3.92% |
AQN | -9.29% | $4.51B | -5.00% | 4.54% |
CNXN | -8.81% | $1.70B | +5.15% | 0.74% |
NATR | -8.64% | $280.09M | +1.13% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KNX | -0.01% | $7.64B | -5.74% | 1.44% |
CYD | 0.04% | $890.68M | +164.07% | 3.83% |
IHRT | 0.05% | $277.53M | +63.48% | 0.00% |
PRGO | 0.06% | $3.75B | +4.09% | 4.14% |
ALLO | 0.06% | $262.48M | -42.31% | 0.00% |
PTCT | -0.06% | $3.90B | +58.55% | 0.00% |
APPF | 0.07% | $8.38B | -6.93% | 0.00% |
MCD | -0.08% | $210.67B | +17.85% | 2.37% |
NKE | -0.09% | $112.75B | +1.53% | 2.05% |
SVV | -0.10% | $1.71B | -11.11% | 0.00% |
COLM | 0.10% | $3.52B | -16.07% | 1.87% |
DLX | 0.11% | $752.97M | -24.09% | 7.09% |
PARAA | -0.11% | $15.57B | +14.88% | 0.87% |
ANGO | 0.11% | $381.30M | +65.32% | 0.00% |
IP | 0.12% | $26.60B | +15.73% | 3.67% |
GRAL | -0.12% | $1.71B | +207.04% | 0.00% |
WOLF | 0.13% | $120.32M | -96.73% | 0.00% |
CXW | 0.13% | $2.30B | +58.20% | 0.00% |
MNOV | 0.14% | $62.29M | -9.29% | 0.00% |
AWR | -0.15% | $2.98B | +8.16% | 2.41% |
SeekingAlpha
Medicus Pharma: High-Risk, But Higher Reward For Their Potential Breakthrough Skin Cancer Treatment
Yahoo
TORONTO, June 27, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that it is completing a non-brokered private placement of class A multiple voting shares (“MVS”) at a price of $50 per MVS, for aggregate gross proceeds of up to $600 (the “Offering”). The Company expects that the entirety of
Yahoo
TORONTO, June 27, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that it is completing a non-brokered private placement of class A multiple voting shares (“MVS”) at a price of $50 per MVS, for aggregate gross proceeds of up to $600 (the “Offering”). The Company expects that the entirety of
Yahoo
Engages leading marketing firm MZ Digital and crowdfunding platform Dealmaker to successfully execute raiseTORONTO, June 26, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces that Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzd™—the scientifically-proven and game-changing beverage that accele
Yahoo
Los Angeles, California--(Newsfile Corp. - June 18, 2025) - Singular Research, a leading provider of independent research on small-cap companies, today released its analysis of Quantum BioPharma Ltd.'s (NASDAQ: QNTM) continued progress across its innovative pipeline of treatments for brain disorders and alcohol health.A link to the report is available here: https://files.constantcontact.com/1683279a601/2551ab59-a629-4103-8f4b-fa3fbf21f4a5.pdf?rdr=trueClinical Development MilestonesQuantum BioPha
Yahoo
Joint Clinical Study with Massachusetts General Hospital Could Pave the Way for Testing Efficacy of Quantum’s Investigational MS drug, Lucid-21-302TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, announces that the first person with multiple sclerosis (MS) has been scanned in a joint study with Ma